UCLA Medical Center Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2014
NCT02232477
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

agnes chen | Charles S. Grob, M.D.

Active Ingredients

Drugs in Other Trials (1)

Laronidase (Aldurazyme) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1